The Sexual Pharmacy

  • Jacinthe FloreEmail author


This chapter examines the pharmaceutical tablet as a technique for the management of sexual appetite in the twenty-first century. It explores the emergence of Addyi (flibanserin) as a case study of how this technique produces a particular subject of pharmaceutical knowledge. The chapter considers the significance of the act of pharmaceutical ingestion on the embodied subjectivity of the consumer and the chemical constitution of the human body. The use of Addyi to manage sexual imbalance in combination with the tools of the diagnostic manual, discussed in Chap.  5, converges in the emergence of a socio-technical and knowledge-gathering subject. This subject is armed with techniques to monitor the self and gather knowledge of her sexual imbalance, a process that affirms intimacy. Indeed, the subject who swallows the pill is a fundamentally social one, that is to say, one who desires intimate contact with others.


  1. Addyi. 2019. Addyi (flibanserin). Accessed 19 Jan 2019.
  2. American Psychiatric Association. 2013. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington, DC: American Psychiatric Association.CrossRefGoogle Scholar
  3. Berlant, Lauren, and Michael Warner. 1998. Sex in Public. Critical Inquiry 24 (2): 547–566.CrossRefGoogle Scholar
  4. Bogaert, Anthony F., and Lori A. Brotto. 2014. Object of Desire Self-Consciousness Theory. Journal of Sex and Marital Therapy 40 (4): 323–338.CrossRefGoogle Scholar
  5. Borsini, F., E. Giraldo, E. Monferini, G. Antonini, M. Parenti, G. Bietti, and A. Donetti. 1995. BIMT 17, a 5-HT2A Receptor Antagonist and 5-HT1A Receptor Full Agonist in Rat Cerebral Cortex. Naunyn Schmiedebergs Archives of Pharmacology 352 (3): 276–282.Google Scholar
  6. Cacchioni, Thea. 2015. Big Pharma, Women and the Labour of Love. Toronto: University of Toronto Press.CrossRefGoogle Scholar
  7. Clayton, A.H., L. Dennerstein, R. Pyke, and M. Sand. 2010. Flibanserin: A Potential Treatment for Hypoactive Sexual Desire Disorder in Premenopausal Women. Women’s Health 6 (5): 639–653.Google Scholar
  8. Drucker, Donna J. 2014. The Machines of Sex: Research Technology and the Politics of Identity, 1945–1985. Dordrecht: Springer.CrossRefGoogle Scholar
  9. Edelman, Lee. 2004. No Future: Queer Theory and the Death Drive. Durham and London: Duke University Press.CrossRefGoogle Scholar
  10. Flore, Jacinthe. 2019. Intimate Tablets: Digital Advocacy and Post-Feminist Pharmaceuticals. Feminist Media Studies 19 (1): 3–18.CrossRefGoogle Scholar
  11. Flower, Rod. 2004. Lifestyle Drugs: Pharmacology and the Social Agenda. TRENDS in Pharmacological Sciences 26 (4): 182–185.CrossRefGoogle Scholar
  12. Food and Drug Administration. 2019. Drug Trials Snapshot: Vyleesi. Accessed 19 July 2019.
  13. ———. 2019. Vyleesi Label. Accessed 19 July 2019.
  14. Foucault, Michel. 2003. Society Must Be Defended: Lectures at the Collège de France, 1975–76. Trans. David Macey. London: Penguin Books.Google Scholar
  15. Gelez, Helene, Pierre Clement, Sandrine Compagnie, Diane Gorny, Miguel Laurin, Kelly Allers, Bernd Sommer, and Francois Giuliano. 2013. Brain Neuronal Activation Induced by Flibanserin Treatment in Female Rats. Psychopharmacology 230: 639–652.CrossRefGoogle Scholar
  16. Georgiadis, J.R., and M.L. Kringelbach. 2012. The Human Sexual Response Cycle: Brain Imaging Evidence Linking Sex to Other Pleasures. Progress in Neurobiology 98: 49–81.CrossRefGoogle Scholar
  17. Halberstam, Judith (Jack). 2005. In a Queer Time and Place: Transgender Bodies, Subcultural Lives. New York: New York University Press.Google Scholar
  18. Haraway, Donna J. 1991. Simians, Cyborgs and Women: The Reinvention of Nature. New York: Routledge.Google Scholar
  19. Harder, Ben. 2005. Potent Medicine: Can Viagra and Other Lifestyle Drug Save Lives? Society for Science & the Public 168 (8): 124–125.Google Scholar
  20. Hitt, Jack. 2000. The Second Sexual Revolution. The New York Times, February 20. Accessed 19 Jan 2019.
  21. Johnson, Michael, Jr. 2010. ‘Just Getting Off’: The Inseparability of Ejaculation and Hegemonic Masculinity. The Journal of Men’s Studies 18 (3): 238–248.CrossRefGoogle Scholar
  22. Laan, Ellen, and Leonore Tiefer. 2014. ‘Pink Viagra’: The Sham Drug Idea of the Year. LA Times, November 13. Accessed 19 Jan 2019.
  23. Lamm, Steven, and Gerald Secor Couzens. 1998. The Virility Solution: Everything You Need to Know About Viagra, the Potency Pill That Can Restore and Enhance Male Sexuality. New York: Fireside Books.Google Scholar
  24. Loe, Meika. 2004. The Rise of Viagra: How the Little Blue Pill Changed Sex in America. New York and London: New York University Press.Google Scholar
  25. Lucke, Jayne. 2015. A Sexually Satisfying Event for Women, or Just a New Identity for an Old Antidepressant. The Conversation, June 6. Accessed 19 January 2019.
  26. Marshall, Barbara L. 2002. ‘Hard Science’: Gendered Constructions of Sexual Dysfunction in the ‘Viagra Age’. Sexualities 5 (2): 131–158.CrossRefGoogle Scholar
  27. ———. 2009. Sexual Medicine, Sexual Bodies and the ‘Pharmaceutical Imagination’. Science as Culture 18 (2): 122–149.CrossRefGoogle Scholar
  28. Martin, Emily. 2006. The Pharmaceutical Person. Biosocieties 1 (3): 273–287.CrossRefGoogle Scholar
  29. McLaren, Angus. 2007. Impotence: A Cultural History. Chicago and London: University of Chicago Press.CrossRefGoogle Scholar
  30. Moynihan, Roy. 2003. The Making of a Disease: Female Sexual Dysfunction. British Medical Journal 326 (7379): 45–47.CrossRefGoogle Scholar
  31. Potts, Annie. 2005. Cyborg Masculinity in the Viagra Era. Sexualities, Evolution and Gender 7 (1): 3–16.CrossRefGoogle Scholar
  32. Preciado, Beatriz (Paul). 2013. Testo Junkie: Sex, Drugs, and Biopolitics in the Pharmacopornographic Era. Trans. Bruce Benderson. New York: The Feminist Press.Google Scholar
  33. Race, Kane. 2009. Pleasure Consuming Medicine: The Queer Politics of Drugs. Durham and London: Duke University Press.CrossRefGoogle Scholar
  34. Rose, Nikolas. 2003. Neurochemical Selves. Society 41 (1): 46–59.CrossRefGoogle Scholar
  35. ———. 2007. Beyond Medicalisation. The Lancet 369: 700–702.CrossRefGoogle Scholar
  36. ———. 2007. The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-First Century. Princeton: Princeton University Press.CrossRefGoogle Scholar
  37. Rose, Nikolas, and Joelle M. Abi-Rached. 2013. Neuro: The New Brain Sciences and the Management of the Mind. Princeton and New York: Princeton University Press.CrossRefGoogle Scholar
  38. Rowland, D.L., and I.G. Motofei. 2015. The Mind and Sexuality: Introduction to a Psychophysiological Perspective. Journal of Mind and Medical Sciences 2 (1): 1–8.Google Scholar
  39. Segal, Judy Z. 2015. The Rhetoric of Female Sexual Dysfunction: Faux Feminism and the FDA. Canadian Medical Association Journal 187 (12): 915–916.CrossRefGoogle Scholar
  40. ———. 2018. Sex, Drugs, and Rhetoric: The Case of Flibanserin for ‘Female Sexual Dysfunction’. Social Studies of Science 48 (4): 459–482.CrossRefGoogle Scholar
  41. Sprout Pharmaceuticals. 2015. Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Premenopausal Women NDA 022526. Advisory Briefing Document.Google Scholar
  42. Stoléru, Serge, Véronique Fonteille, Christel Cornélis, Christian Joyal, and Virginie Moulier. 2012. Functional Neuroimaging Studies of Sexual Arousal and Orgasm in Healthy Men and Women: A Review and Meta-analysis. Neuroscience and Biobehavioral Reviews 36: 1481–1509.CrossRefGoogle Scholar
  43. Tiefer, Leonore. 2002. Arriving at a ‘New View’ of Women’s Sexual Problems: Background, Theory and Activism. Women & Therapy 24 (1–2): 63–98.CrossRefGoogle Scholar
  44. ———. 2004. Sex Is Not a Natural Act and Other Essays. New York: Westview Press.Google Scholar
  45. ———. 2006. The Viagra Phenomenon. Sexualities 9 (3): 273–294.CrossRefGoogle Scholar
  46. Viagra. 2019. Learning: How Does Viagra Work? Accessed 19 Jan 2019.
  47. Wilson, Elizabeth A. 2015. Gut Feminism. Durham and London: Duke University Press.CrossRefGoogle Scholar

Copyright information

© The Author(s) 2020

Authors and Affiliations

  1. 1.Royal Melbourne Institute of TechnologyMelbourneAustralia

Personalised recommendations